Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2015

Sep 24, 2015

32414_dirs_2015-09-24_2fc31711-af38-4c39-bbd7-f74b8cd94738.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2015-09-22

Reporting Person: Donovan Michael Patrick (Vice President, Operations)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $0.27 2018-01-13 Common Stock (4659) Direct
Employee Stock Option (right to buy) $2.74 2018-12-16 Common Stock (35000) Direct
Employee Stock Option (right to buy) $2.90 2020-01-04 Common Stock (1500) Direct
Employee Stock Option (right to buy) $4.81 2021-01-02 Common Stock (5000) Direct
Employee Stock Option (right to buy) $3.67 2021-12-29 Common Stock (10000) Direct

Footnotes

F1: All shares pursuant to the employee stock option became fully vested on January 13, 2015 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on January 13, 2012 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

F2: All shares pursuant to the employee stock option will be fully vested on December 16, 2015 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 16, 2012 (12 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.

F3: All shares pursuant to the employee stock option will be fully vested on January 2, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on January 2, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.

F4: All shares pursuant to the employee stock option will be fully vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares will vest on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares will vest each 6 months thereafter.